Cargando…

Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways

Kaempferol has been reported to exhibit beneficial effect on the osteogenic differentiation in mesenchymal stem cells (MSC) and osteoblasts. In our previous study, dexamethasone (DEX) demonstrated inhibitory effect on MC3T3-E1 cells differentiation. In this study, we mainly explored the protective e...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Baocheng, Zeng, Zhanwei, Liao, Shiyi, Zhou, Chenhui, Wu, Longhuo, Xu, Daohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524096/
https://www.ncbi.nlm.nih.gov/pubmed/34675808
http://dx.doi.org/10.3389/fphar.2021.739326
_version_ 1784585440222773248
author Xie, Baocheng
Zeng, Zhanwei
Liao, Shiyi
Zhou, Chenhui
Wu, Longhuo
Xu, Daohua
author_facet Xie, Baocheng
Zeng, Zhanwei
Liao, Shiyi
Zhou, Chenhui
Wu, Longhuo
Xu, Daohua
author_sort Xie, Baocheng
collection PubMed
description Kaempferol has been reported to exhibit beneficial effect on the osteogenic differentiation in mesenchymal stem cells (MSC) and osteoblasts. In our previous study, dexamethasone (DEX) demonstrated inhibitory effect on MC3T3-E1 cells differentiation. In this study, we mainly explored the protective effect of kaempferol on the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells. We found that kaempferol ameliorated the proliferation inhibition, cell cycle arrest, and cell apoptosis and increased the activity of alkaline phosphatase (ALP) and the mineralization in DEX-treated MC3T3-E1 cells. Kaempferol also significantly enhanced the expression of osterix (Osx) and runt-related transcription factor 2 (Runx2) in MC3T3-E1 cells treated with DEX. In addition, kaempferol attenuated DEX-induced reduction of cyclin D1 and Bcl-2 expression and elevation of p53 and Bax expression. Kaempferol also activated JNK and p38-MAPK pathways in DEX-treated MC3T3-E1 cells. Furthermore, kaempferol improved bone mineralization in DEX-induced bone damage in a zebrafish larvae model. These data suggested that kaempferol ameliorated the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells by activating JNK and p38-MAPK signaling pathways. Kaempferol exhibited great potentials in developing new drugs for treating glucocorticoid-induced osteoporosis.
format Online
Article
Text
id pubmed-8524096
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85240962021-10-20 Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways Xie, Baocheng Zeng, Zhanwei Liao, Shiyi Zhou, Chenhui Wu, Longhuo Xu, Daohua Front Pharmacol Pharmacology Kaempferol has been reported to exhibit beneficial effect on the osteogenic differentiation in mesenchymal stem cells (MSC) and osteoblasts. In our previous study, dexamethasone (DEX) demonstrated inhibitory effect on MC3T3-E1 cells differentiation. In this study, we mainly explored the protective effect of kaempferol on the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells. We found that kaempferol ameliorated the proliferation inhibition, cell cycle arrest, and cell apoptosis and increased the activity of alkaline phosphatase (ALP) and the mineralization in DEX-treated MC3T3-E1 cells. Kaempferol also significantly enhanced the expression of osterix (Osx) and runt-related transcription factor 2 (Runx2) in MC3T3-E1 cells treated with DEX. In addition, kaempferol attenuated DEX-induced reduction of cyclin D1 and Bcl-2 expression and elevation of p53 and Bax expression. Kaempferol also activated JNK and p38-MAPK pathways in DEX-treated MC3T3-E1 cells. Furthermore, kaempferol improved bone mineralization in DEX-induced bone damage in a zebrafish larvae model. These data suggested that kaempferol ameliorated the inhibitory activity of DEX in the osteogenesis of MC3T3-E1 cells by activating JNK and p38-MAPK signaling pathways. Kaempferol exhibited great potentials in developing new drugs for treating glucocorticoid-induced osteoporosis. Frontiers Media S.A. 2021-10-05 /pmc/articles/PMC8524096/ /pubmed/34675808 http://dx.doi.org/10.3389/fphar.2021.739326 Text en Copyright © 2021 Xie, Zeng, Liao, Zhou, Wu and Xu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Xie, Baocheng
Zeng, Zhanwei
Liao, Shiyi
Zhou, Chenhui
Wu, Longhuo
Xu, Daohua
Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title_full Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title_fullStr Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title_full_unstemmed Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title_short Kaempferol Ameliorates the Inhibitory Activity of Dexamethasone in the Osteogenesis of MC3T3-E1 Cells by JNK and p38-MAPK Pathways
title_sort kaempferol ameliorates the inhibitory activity of dexamethasone in the osteogenesis of mc3t3-e1 cells by jnk and p38-mapk pathways
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524096/
https://www.ncbi.nlm.nih.gov/pubmed/34675808
http://dx.doi.org/10.3389/fphar.2021.739326
work_keys_str_mv AT xiebaocheng kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways
AT zengzhanwei kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways
AT liaoshiyi kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways
AT zhouchenhui kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways
AT wulonghuo kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways
AT xudaohua kaempferolamelioratestheinhibitoryactivityofdexamethasoneintheosteogenesisofmc3t3e1cellsbyjnkandp38mapkpathways